Form 8-K - Current report:
SEC Accession No. 0000318154-20-000058
Filing Date
2020-10-28
Accepted
2020-10-28 16:03:29
Documents
16
Period of Report
2020-10-28
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K amgn-20201028.htm   iXBRL 8-K 54795
2 EX-99.1 amgn-2020930xq3ex991.htm EX-99.1 497194
3 GRAPHIC amgenlogoa141.jpg GRAPHIC 6206
  Complete submission text file 0000318154-20-000058.txt   804247

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT amgn-20201028.xsd EX-101.SCH 3584
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT amgn-20201028_cal.xml EX-101.CAL 740
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT amgn-20201028_def.xml EX-101.DEF 18396
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT amgn-20201028_lab.xml EX-101.LAB 35976
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT amgn-20201028_pre.xml EX-101.PRE 18799
9 EXTRACTED XBRL INSTANCE DOCUMENT amgn-20201028_htm.xml XML 15954
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (805)447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

EIN.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37702 | Film No.: 201268632
SIC: 2836 Biological Products, (No Diagnostic Substances)